Trial Search Results

Online Automated Self-Hypnosis Program

After developing professional quality materials (audio) for an inexpensive automated self-hypnosis intervention program for treating smoking cessation, researchers aim to gain qualitative reviews of this program, and test its initial feasibility and effects on smoking cessation.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Stanford Investigator(s):


  • Behavioral: Automated Self-Hypnosis




Inclusion Criteria:

   - 18 years or older

   - Able to read and understand English

   - Desire to quit smoking (specifically, report a motivation of ≥ 5 out of 10 to quit
   smoking on a 10-point Likert-type scale)

   - Having access to wireless internet connection or mobile data

   - Reporting being a daily smoker for at least one year, smoking an average ≥ 5
   cigarettes per day

Exclusion Criteria:

   - Meeting criteria for drug abuse of depressants, dissociative anesthetics,
   hallucinogens, opioids, cocaine, or amphetamine within the last 3 months.

   - Severe psychiatric or structural brain disease (i.e. psychosis, stroke with functional
   impairment, dementia) or [current/recent risk to self. Indicated by denial of question
   pertaining to inpatient hospitalization

   - Hearing impairment that would impede ability to listen the auditory intervention

   - Major illnesses impacting the study results

   - Currently taking Wellbutrin, Chantix, or other pharmacological smoking cessation aids
   that could confound results of the study

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study


Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
David Spiegel